Physician profile
Kyle Forsyth
NPI 1629183033
$4,700.72
in general payments reported to CMS, 2019-2025
39 companies · $1,371 in 2025
The $1,371 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $49.65 · 2021: $16.58 · 2022: $600 · 2023: $1,252 · 2024: $1,125 · 2025: $1,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,748.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $776.52 | 2022-2025 | |
| Lilly USA, LLC | $456.37 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $405.80 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $374.25 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.69 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $289.70 | 2022-2025 | Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $276.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bausch Health US, LLC | $120.46 | 2019-2024 | Aplenzin, Wellbutrin |
| Corium, LLC | $120.09 | 2023-2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $115.68 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amgen INC. | $115.54 | 2019-2023 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $115.30 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
| Scpharmaceuticals INC. | $115.00 | 2024 | |
| Seqirus USA INC | $106.51 | 2022-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Exact Sciences Corporation | $106.37 | 2023-2025 | Cologuard Collection Kit |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Forsyth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.